Home  >  Products  >  LGALS9 (lectin, galactoside-binding, soluble, 9 (galectin 9)) Blocking Peptide (100ug)
LGALS9 (lectin, galactoside-binding, soluble, 9 (galectin 9)) Blocking Peptide (100ug)

LGALS9 (lectin, galactoside-binding, soluble, 9 (galectin 9)) Blocking Peptide (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-LGALS9 antibody (Catalogue #: ARP54821_P050) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP54821
Size: 100 ug
Weight: 39kDa
Gene: 3965
Format: Lyophilized powder
Target: The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. LGALS9 is an S-type lectin. It is overexpressed in Hodgkin's disease tissue and might participate in the interaction between the H&RS cells with their surrounding cells and might thus play a role in the pathogenesis of this disease and/or its associated immunodeficiency.The galectins are a family of beta-galactoside-binding proteins implicated in modulating cell-cell and cell-matrix interactions. The protein encoded by this gene is an S-type lectin. This galectin is strongly overexpressed in Hodgkin's disease tissue and it might participate in the interaction between the H&RS cells with their surrounding cells and might thus play a role in the pathogenesis of this disease and/or its consistently associated immunodeficiency. The protein has N- and C- terminal carbohydrate-binding domains connected by a link peptide. Multiple alternatively spliced transcript variants have been found for this gene.
Alternative names: ECALECTIN; HUAT; MGC117375; MGC125973; MGC125974; galectin-9
See Full Product Listings >